Indirect comparison of TPF and GP induction chemotherapy regimens in nasopharyngeal carcinoma: a data-driven reassessment before the transition to induction chemoimmunotherapy.

IF 4.8 2区医学 Q1 ONCOLOGY

Oncologist Pub Date : 2025-06-24 DOI:10.1093/oncolo/oyaf175

Stefano Cavalieri, Arianna Ottini, Benedetta Lombardi Stocchetti, Lisa Licitra

引用次数: 0

查看原文本刊更多论文

鼻咽癌TPF和GP诱导化疗方案的间接比较：在过渡到诱导化疗免疫治疗之前的数据驱动的重新评估。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Oncologist 医学-肿瘤学

CiteScore

10.40

自引率

3.40%

发文量

309

审稿时长

3-8 weeks

期刊介绍： The Oncologist® is dedicated to translating the latest research developments into the best multidimensional care for cancer patients. Thus, The Oncologist is committed to helping physicians excel in this ever-expanding environment through the publication of timely reviews, original studies, and commentaries on important developments. We believe that the practice of oncology requires both an understanding of a range of disciplines encompassing basic science related to cancer, translational research, and clinical practice, but also the socioeconomic and psychosocial factors that determine access to care and quality of life and function following cancer treatment.